Clinical trials
Completed Major Depressive Disorder trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lundbeck A/S | 6 |
| Eli Lilly and Company | 5 |
| Janssen Research & Development, LLC | 3 |
| AstraZeneca | 2 |
| GlaxoSmithKline | 2 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Aziende Chimiche Riunite Angelini Francesco S.p.A | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Institute of Neuroscience, Florence, Italy | 1 |
| Janssen-Cilag S.p.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 24 |
| Anhedonia | 1 |
| Dementia | 1 |
| Depressive Disorder | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Migraine Disorders | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.